ASTRAEA THERAPEUTICS LLC has a total of 19 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are MSD KK, FLYNN DANIEL L and MEDIFRON DBT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Australia | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Zaveri Nurulain T | 12 |
#2 | Toll Lawrence | 8 |
#3 | Yasuda Dennis | 8 |
#4 | Jiang Faming | 8 |
#5 | Meyer Michael | 7 |
#6 | Zaveri Nurulain | 5 |
#7 | Journigan V Blair | 5 |
#8 | Journigan Blair V | 1 |
Publication | Filing date | Title |
---|---|---|
EP3383390A1 | Piperidinyl nociceptin receptor compounds | |
US2018155314A1 | Piperdinyl nociceptin receptor compounds | |
CN102905527A | Nicotinic acetylcholine receptor modulators |